Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma.

Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant pleural mesothelioma. Lung Cancer. 2014 Sep; 85(3):429-34.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
cdc25 Phosphatases
Cisplatin
Female
Glutamates
Guanine
Humans
Lung Neoplasms
Male
Mesothelioma
Middle Aged
Neoplasm Staging
Pemetrexed
Peptide Fragments
Treatment Outcome

authors with profiles

Hedy Kindler